Skip to main content
Clinical Trials/NCT04949204
NCT04949204
Completed
Not Applicable

Contextuele Analyse, Fysiologische Metingen en Machinaal Leren Voor Migraine en Clusterhoofdpijn (COPIMAC Studie)

University Hospital, Ghent1 site in 1 country19 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine
Sponsor
University Hospital, Ghent
Enrollment
19
Locations
1
Primary Endpoint
Galvanic Skin Response changes
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This is an observational, longitudinal cohort pilot study measuring physiological signals through wearable sensors combined with machine learning algorithms to detect behaviour, stress and headaches in patients with migraine and cluster headache.

Detailed Description

Migraine and cluster headache are among the most disabling headache conditions in humans. Both conditions have different phases such as the prodromal/premonitory phase, the aura phase, the headache phase and the postdromal phase. This pilot study examines the potential of wearable sensors combined with machine learning algorithms to investigate the biological changes over time in both conditions. Behaviour such as movement, sleep and activity will be monitored. Stress levels will be estimated through the wearable data combined with input from the patients. Participants will use a wearable device around the wrist and self-developed headache application for 21 days.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
July 31, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • migraine or cluster headache diagnosis based on ICHD 3 criteria
  • at least 2 attacks each month
  • onset of headache syndrome before the age of 50
  • if multiple headache syndromes coexist: attacks are clearly distinguishable
  • participant has smartphone that he/she wants to apply for this research

Exclusion Criteria

  • chronic migraine patients
  • history of alcohol or illicit drug abuse
  • significant medical comorbidity deemed by the investigator to interfere with the study
  • use of betablockers
  • participating in other academic or commercial trials

Outcomes

Primary Outcomes

Galvanic Skin Response changes

Time Frame: 21 days

Changes in GSR through the different phases of the headache attacks

Secondary Outcomes

  • Activity ratio(21 days)
  • Skin temperature(21 days)

Study Sites (1)

Loading locations...

Similar Trials